Woodrow D. Anderson

CIK: 0002014440

Transaction Breakdown

Open Market Buys (P)2 (25.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (25.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INDV

Indivior Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

INDV
Indivior Pharmaceuticals, Inc.
Aug 27, 2026
Purchase(P)
Direct
1.5K shares at avg. $35.69$54K
INDV
Indivior Pharmaceuticals, Inc.
Aug 5, 2026
Purchase(P)
Direct
1.5K shares at avg. $36.28$54K
INDV
Indivior Pharmaceuticals, Inc.
Mar 3, 2026
Exercise(M)
Direct
5.9K shares-
INDV
Indivior Pharmaceuticals, Inc.
Mar 3, 2026
Tax Payment(F)
Direct
2.7K shares at avg. $31.98$86K
INDV
Indivior Pharmaceuticals, Inc.
Mar 3, 2026
Exercise(M)
Direct
18.4K shares-
INDV
Indivior Pharmaceuticals, Inc.
Mar 3, 2026
Tax Payment(F)
Direct
8.3K shares at avg. $31.98$265K
INDV
Indivior Pharmaceuticals, Inc.
Feb 10, 2026
Award(A)
Direct
6.9K shares-
INDV
Indivior Pharmaceuticals, Inc.
Feb 9, 2026
Award(A)
Performance Stock Units
Direct
24K shares-

		Type	Shares	Price		Ownership
Aug 27, 2026	INDV Indivior Pharmaceuticals, Inc.	Purchase(P)	1,500	$35.69	$53,535	Direct
Aug 5, 2026	INDV Indivior Pharmaceuticals, Inc.	Purchase(P)	1,500	$36.28	$54,420	Direct
Mar 3, 2026	INDV Indivior Pharmaceuticals, Inc.	Exercise(M)	5,946	-	$0	Direct
Mar 3, 2026	INDV Indivior Pharmaceuticals, Inc.	Tax Payment(F)	2,682	$31.98	$85,770	Direct
Mar 3, 2026	INDV Indivior Pharmaceuticals, Inc.	Exercise(M)	18,364	-	$0	Direct
Mar 3, 2026	INDV Indivior Pharmaceuticals, Inc.	Tax Payment(F)	8,283	$31.98	$264,890	Direct
Feb 10, 2026	INDV Indivior Pharmaceuticals, Inc.	Award(A)	6,903	-	$0	Direct
Feb 9, 2026	INDV Indivior Pharmaceuticals, Inc.	Award(A) Performance Stock Units	23,975	-	-	Direct

1-8 of 8 transactions

About Anderson Woodrow D

Anderson Woodrow D (SEC CIK 0002014440) files insider reports with the SEC as Chief Accounting Officer of Indivior Pharmaceuticals, Inc. (INDV).

Signal8 holds 5 ownership filings by Anderson Woodrow D (1 Form 3, 4 Form 4), filed between Jan 7, 2026 and Aug 27, 2026. Those filings report 8 transactions, from Feb 9, 2026 to Aug 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Anderson Woodrow D's filings is in NORTH CHESTERFIELD, VA.

Recent filings by Anderson Woodrow D

Aug 27, 2026: Open-market purchase of INDV shares (Form 4, code P).
Aug 5, 2026: Open-market purchase of INDV shares (Form 4, code P).
Mar 3, 2026: Option exercise of INDV shares (Form 4, code M).
Mar 3, 2026: Tax withholding of INDV shares (Form 4, code F).
Mar 3, 2026: Option exercise of INDV shares (Form 4, code M).

Other insiders filing for Indivior Pharmaceuticals, Inc. (INDV)

Heidbreder Christian, Chief Scientific Officer
Ciaffoni Joseph, Chief Executive Officer
Preblick Ryan, Chief Financial Officer
Thompson Juliet, Director
Humphreys Keith, Director
Kingsley Stuart A, Director

How to read Form 4 transaction codes